BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36948667)

  • 1. Diseases of Hereditary Renal Cell Cancers.
    Iliopoulos O
    Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Renal Cancer Syndromes.
    Yanus GA; Kuligina ES; Imyanitov EN
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Strategies for Hereditary Kidney Cancer: Current Recommendations and Updates.
    Singh S; Chaurasia A; Gopal N; Malayeri A; Ball MW
    Discov Med; 2022; 34(173):205-220. PubMed ID: 36602871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary kidney cancer: unique opportunity for disease-based therapy.
    Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
    Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Renal Cell Carcinoma Syndromes.
    Carlo MI
    Hematol Oncol Clin North Am; 2023 Oct; 37(5):841-848. PubMed ID: 37258351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.
    Kallinikas G; Habib H; Tsimiliotis D; Koutsokostas E; Bokor B
    Int Urol Nephrol; 2017 Sep; 49(9):1507-1512. PubMed ID: 28567709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of hereditary renal cancer syndromes: a pending issue for oncologists.
    García-Donas J; Hernando S; Romero N; Jara C
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S15-20. PubMed ID: 21173603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
    Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
    Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumarate hydratase as a therapeutic target in renal cancer.
    Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G
    Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited renal carcinomas.
    Kawashima A; Young SW; Takahashi N; King BF; Atwell TD
    Abdom Radiol (NY); 2016 Jun; 41(6):1066-78. PubMed ID: 27108134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary kidney cancer syndromes.
    Haas NB; Nathanson KL
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):81-90. PubMed ID: 24359990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic kidney cancer syndromes.
    Ho TH; Jonasch E
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
    Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
    Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
    Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
    Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
    Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary renal tumor syndromes.].
    Sánta F; Semjén D; Kuthi L
    Orv Hetil; 2023 Mar; 164(10):363-375. PubMed ID: 36906860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study.
    Wen H; Zheng L; Zhang M; Pan X; Wang D; Qian J; Zhang X; Zhou Q; Chen N
    Int J Surg Pathol; 2024 Jun; 32(4):810-816. PubMed ID: 37715637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis.
    Alchoueiry M; Cornejo K; Henske EP
    Semin Diagn Pathol; 2024 Jan; 41(1):1-7. PubMed ID: 38008653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.